Bahamas vs Sur: Previously treated cases tested for RR-/MDR-TB
Bahamas
100.0%
in 2020
Sur
62.0%
in 2024
Bahamas rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Bahamas
- Sur
How they compare
Bahamas currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Bahamas's figure about 1.6 times Sur's.
The two have swapped places 4 times across 10 shared years of data; in 2008 it was Bahamas ahead.
Bahamas ranks 1st and Sur ranks 2nd of 180 countries.
Across the 3 decades both report, Bahamas averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Bahamas | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.5% | 21.5% | 56.0% | Bahamas |
| 2010s | 52.4% | 55.4% | 3.0% | Sur |
| 2020s | 100.0% | 62.0% | 38.0% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bahamas or Sur?
- Bahamas, at 100.0% against 62.0% in Sur as of 2020.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bahamas and Sur?
- 38.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Sur?
- 10 years are reported by both, from 2008 to 2020.
- How do Bahamas and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Bahamas ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.